looks the same sort of opportunistic buy - ie other side of larger, eager seller - in this case Lodestone's 11m ?like the syle
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025